Objectives: To investigate the presumed acquisition of ampicillin resistance by an Escherichia coli strain residing in the gut of an infant.
Introduction
Antimicrobial resistance genes are often associated with conjugative plasmids or transposons, which encode the proteins necessary to initiate and complete their transfer to new hosts.
The human large intestine has been proposed as a suitable environment for gene exchange. Recently, transfer of a plasmidmediated ACC-1 b-lactamase from a Klebsiella pneumoniae strain to an Escherichia coli strain during antibiotic treatment of an infant was reported. 1 Facultative bacteria, such as E. coli, reach much higher population levels in the gut flora of infants than in adults, as many strict anaerobes do not establish until individuals are several years old. 2 This fact may enhance the possibility of gene exchange between facultative bacteria in the infantile microbiota. Here, we demonstrate that a plasmid carrying a b-lactamase gene appears to have been transferred from an ampicillinresistant E. coli strain to an initially susceptible strain during their co-residence in the infantile gut.
Materials and methods

Study protocol
The infant studied here participated in the ALLERGYFLORA study, which examines the relationship between intestinal colonization A rectal swab was obtained at 2 -3 days of age and stool samples were collected at 1, 2 and 4 weeks of age and at 2, 6 and 12 months of age and cultivated quantitatively for all major groups of facultative and anaerobic bacteria. E. coli were quantified on Drigalski agar and various colony types were enumerated separately and speciated using API 20E identification strips (bioMérieux, Marcy-l'É toile, France). All E. coli isolates were identified to the strain level using random amplified polymorphic DNA (RAPD) analysis. 3 Confirmation of strain identity was performed using PFGE and the strains were subjected to complete (O:K:H) serotyping at the Statens Serum Institut (Copenhagen, Denmark). Strains were also characterized with respect to phylogenetic group identity (A, B1, B2 or D) and virulence genes by PCR as described previously. 3, 4 Antibiotic susceptibility, isoelectric focusing and DNA sequencing E. coli isolates were tested for susceptibility to: ampicillin, amoxicillin/clavulanic acid, piperacillin, mecillinam, cefadroxil, ceftazidime, cefuroxime, cefoxitin, chloramphenicol, gentamicin, tobramycin, streptomycin, nitrofurantoin, nalidixic acid, tetracycline, trimethoprim and sulphonamide using the disc diffusion method (Oxoid, Sollentuna, Sweden). 5 The MIC of ampicillin was determined by Etest.
5 b-Lactamases were characterized by isoelectric focusing at The Swedish Institute for Infectious Disease Control (SMI), as previously described. 6 The presence of the bla TEM gene was determined by PCR, 7, 8 followed by DNA sequencing of the products. The promoters of ampC genes were also sequenced. 8 
Plasmid characterization
Total plasmid DNA was prepared (Plasmid Mini Kit, Qiagen) and transformed into E. coli DH5a (Invitrogen, Carlsbad, CA, USA). Transformants were selected on agar plates containing ampicillin (50 mg/L). Plasmid DNA was treated with HindIII and separated on a 0.7% agarose gel, stained with ethidium bromide, and visualized under UV-light.
For Southern-blot hybridization, cleavage products were transferred onto a nylon membrane (Amersham, Uppsala, Sweden), hybridized with a digoxigenin-labelled TEM probe (Roche Diagnostics GmbH, Mannheim, Germany), detected with antidigoxigenin-AP and visualized with a colorimetric substrate (Roche Diagnostics).
Transfer of resistance by conjugation
Conjugation experiments were performed by the broth method, using E. coli DH5a as the recipient and ampicillin-resistant E. coli isolates obtained from the infant studied as donors. To investigate in vitro plasmid transfer from strain 29A to 29B, a high-level streptomycin-resistant mutant of strain 29B was selected. Transconjugants were selected on LB agar containing ampicillin (50 mg/L) and nalidixic acid (50 mg/L) or streptomycin (1 g/L), while donor frequency was estimated by plating a dilution of the conjugation mixture onto LB agar containing ampicillin.
Results and discussion
Detection of transfer of antibiotic resistance and confirmation of strain identities During screening of 272 E. coli strains from 128 infants in the ALLERGYFLORA birth-cohort study for antibiotic resistance, we identified an E. coli strain that became resistant during the course of colonization of a newborn infant's bowel. The boy was born in 1999 by normal vaginal delivery. He was admitted to hospital at 8 days of age, due to a suspected urinary tract infection, and trimethoprim was administered for 5 days. A urinary culture yielded E. coli at 100 000 cfu/mL. Due to the presence of enterococci in addition to E. coli in a second urinary sample, antibiotic treatment was switched to intravenous ampicillin for 5 days, followed by amoxicillin perorally for an additional 8 days. Finally, trimethoprim was administered prophylactically for 7 months according to clinical routine.
The infant carried two faecal E. coli strains during the first month of life. One strain, termed 29A, colonized the infant's bowel from 2 days until 1 year of age and was retrieved from seven consecutive stool samples. All isolates of strain 29A were highly resistant to ampicillin (MIC ! 256 mg/L). Although all isolates were resistant to piperacillin (zone diameter 14 mm), the isolates obtained at 32 days and at 2, 6 and 12 months of age had a smaller zone diameter of 6 mm than those obtained earlier. All isolates of strain 29A were fully susceptible to the other antibiotics tested. Strain 29A had the O134:K1:H31 serotype and all isolates were identical according to RAPD and PFGE typing, virulence factor gene carriage (fimA, neuB) and phylogenetic group identity (D).
Another E. coli strain, termed 29B, was detected in the faecal samples obtained from the boy at 9, 16 and 32 days of age. The isolates of strain 29B obtained on the first two occasions were susceptible to all antibiotics tested (termed 29B S ), whereas the isolate obtained at 32 days of age (termed 29B R ) was resistant to ampicillin (MIC ! 256 mg/L) and piperacillin (zone diameter 14 mm). Strain 29B had the O15:K52:H1 serotype, which is typical of a globally spread pyelonephritogenic clone. A specific PCR assay confirmed that all isolates of strain 29B belonged to this clonal group. 9 All isolates of strain 29B were homogenous with respect to RAPD pattern and virulence gene profile (fimA, iutA) and belonged to phylogenetic group D.
Characterization of b-lactamases
Isolates of strain 29A, 29B S and 29B R were analysed by isoelectric focusing to detect b-lactamases that may have been responsible for the observed resistance. Strain 29A was found to harbour two b-lactamases, whose pIs were 5.4 and 9.0, respectively. A pI of 5.4 is characteristic of enzymes of the TEM-1 type, whereas a pI of 8.6/9.0 is instead characteristic of AmpC b-lactamases. The ampC gene is ubiquitous in E. coli, but is normally expressed at low levels, insufficient to mediate phenotypic resistance. The isolate 29B
S contained a single b-lactamase with a pI of 8.6. Since this isolate was not phenotypically resistant, and since the pI was typical of an AmpC b-lactamase, we assumed that strain 29B carried a chromosomal ampC gene expressed at a low level. The isolate 29B R carried two b-lactamases, one of pI 8.4/8.6 (assumed to represent the AmpC b-lactamase) and another of pI 5.4, typical of TEM-1-type b-lactamases. Sequence analysis of ampC promoters did not show any changes in the different isolates of strain A or B, indicating that AmpC up-regulation did not occur in these isolates.
PCR and DNA sequencing revealed the presence of the same molecular variant of bla TEM-1b in isolates 29A and 29B R , but not in 29B S . We also analysed the promoter region of the bla TEM amplicons. A weak promoter (P3) and two strong overlapping (Pa/Pb) promoters have been described for bla TEM genes. 10 The weak P3 promoter was found in the strain 29A isolate recovered at 2 days of age and the 29B R isolate. The strong Pa/Pb promoter was found in isolates of strain 29A recovered at 32 days and 6 months of age after treatment of the colonized infant with ampicillin and amoxicillin. The occurrence of the stronger promoter coincided with a decreased piperacillin zone and decreased susceptibility to amoxicillin/clavulanic acid. Thus, the TEM-1 promoter underwent changes in strain 29A during persistence of the strain in the bowel, after it had transferred its bla TEM gene to strain 29B and while the infant received treatment with ampicillin and amoxicillin.
Plasmid characterization
We examined plasmid similarity between strain 29A and strain 29B by restriction fragment length polymorphism analysis. Three plasmid DNA fragments, $5, 10 and 15 -20 kb in size derived from a plasmid of $40 kb in size (termed pNK29), were detected in the 29A and 29B R isolates, but were absent in the 29B S isolate. The same three fragments were also detected in E. coli DH5a transformed with 29A plasmid DNA (Figure 1a) . Plasmid DNA fragments were subjected to Southern-blot hybridization with a bla TEM -specific probe, which hybridized to a 10 kb band in the plasmid DNA digests from isolates 29A, 29B R and the transformant, but not to DNA obtained from the isolate 29B S (Figure 1b) . Transconjugation experiments demonstrated that pNK29 could be transferred from isolates 29A and 29B
R to E. coli DH5a at frequencies of 4 Â 10 28 and 8 Â 10 27 transconjugants per donor, respectively. pNK29 could also be transferred from strain 29A to a high-level streptomycin-resistant mutant of 29B S at a frequency of 3 Â 10 210 transconjugants per donor.
The lower transfer frequency of pNK29 from strain 29A to strain 29B S than to E. coli DH5a suggests that transmission of pNK29 from strain 29A to strain 29B might only occur during strongly predisposing conditions, i.e. treatment of the infant with ampicillin and amoxicillin.
Microbiota population levels of individual E. coli strains
The population counts of all strains on all culture occasions were determined by separately enumerating each colony and assessing its strain identity by RAPD. Strains 29A and 29B had similar faecal population counts (10 8.3 and 10 8.6 cfu/g) at 9 days of age. At 16 days of age, after 1 week of trimethoprim treatment, the population levels of both strains were reduced (10 6.4 and 10 3.9 cfu/g), especially that of strain 29B. As the child was switched to ampicillin and amoxicillin, the faecal population counts of strain 29A rose dramatically to 10 11 cfu/g at 32 days of age, a level rarely obtained under normal conditions (only 3 out of 272 strains had this high population level). The increase in E. coli faecal population counts coincided with a drop in anaerobic, especially bifidobacterial population levels. Strain 29B, which appeared to have acquired ampicillin resistance between 16 and 32 days of age, also had a very high population density, i.e. 10 10.3 cfu/g of faeces at 32 days of age. The high population counts of strain 29A may have facilitated its ability to act as a donor of a resistance plasmid. When conjugation occurred, the presence of ampicillin in the intestinal microbiota would confer an immediate advantage on the recipient of pNK29. This was clearly reflected in the counts of strain 29B.
Conclusions
These observations provide conclusive evidence of gene transfer in the human commensal bowel microbiota in a child treated with ampicillin. Our results could indicate that antibiotics may not only select for resistant bacteria, but may also increase their potential as donors of resistance genes by increasing their population counts, a serious consequence that has previously received little consideration. This suspicion may indicate that closer attention should be paid to the ecological effects of antibiotic treatment on the commensal microbiota. 
